Palantir's stock fell 3.33% to $126.28 following news that director Alexander D. Moore sold $2.13 million worth of shares under a pre-planned trading plan. This sale is part of a broader pattern of insider selling this year, including significant sales by other executives like Lauren Friedman Stat, Shyam Sankar, and Stephen Cohen. The insider sales coincide with a nearly 25% year-to-date decline in Palantir's share price, signaling possible concerns about the company's near-term outlook. Investors should watch for further insider activity and market reactions.
President Trump's May 2026 financial disclosure revealed over 3,600 stock trades in Q1 2026, focusing on AI infrastructure firms like NVIDIA, AMD, and Broadcom during a market dip. These companies supply critical technology for AI growth, with strong...
Before closing his fund in late 2025, Michael Burry's last 13F filings revealed put options against AI-focused stocks NVIDIA and Palantir, paired with a large investment in health insurer Molina Healthcare. Burry's bearish stance on NVIDIA and Palant...
Palantir Technologies continues to be rated a Strong Buy due to its accelerating revenue growth and significant government contracts, which are not yet fully reflected in its stock price. The recent stock pullback is attributed to valuation compressi...
Palantir Technologies (PLTR) is rated 'Buy' following a significant 37% stock pullback. The company posted strong Q1 results with 85% year-over-year revenue growth and a 60% EBIT margin, beating expectations on both revenue and profit. Strategic part...
An analyst rates Palantir Technologies as a Buy with a price target of $183, suggesting a 41% upside from the current price of $130. Key growth drivers include US commercial AI adoption, government and defense AI projects, sovereign AI infrastructure...
